Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TLR3–TRIF signaling pathway is a critical component of the innate immune response, primarily responsible for detecting viral double-stranded RNA (dsRNA) and initiating antiviral defenses. Toll-like receptor 3 (TLR3), upon recognizing dsRNA, activates downstream signaling exclusively through the adaptor protein TRIF (TIR-domain-containing adapter-inducing interferon-β). Upon dsRNA binding, TLR3 activates NF-κB/MAPK and IRF3/Type I Interferon pathways, leading to the production of type I interferons and proinflammatory cytokines/chemokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TLR3–TRIF Signaling Pathway (TLR3-TRIF pathway).